Market Tracker

03/24 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.40
Delayed Data
As of Mar 24
 +0.15 / +12.00%
Today’s Change
0.94
Today|||52-Week Range
8.90
-37.78%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.25
Today’s open1.35
Day’s range1.25 - 1.55
Volume4,282,684
Average volume (3 months)849,916
Market cap$74.1M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+9.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc-0.17-4.07%
FLKSFlex Pharma Inc-0.05-1.23%
CAPRCapricor Therapeutic...+0.16+4.98%
TTNPTitan Pharmaceutical...+0.05+1.52%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts